RGT 2.90% 35.5¢ argent biopharma limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6

  1. 14,010 Posts.
    lightbulb Created with Sketch. 2383
    It is difficult to see that there is much value in buying out MXC - they do have European assets - Malta/Slovenia growing facilities, GMP licences etc. Maybe a buyer wishing to go in a different direction might find these of some value. Can't imagine that they would be worth more than $100mil - and that is a premium price.

    Most current holders in MXC would lose out.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.